Induced Pluripotent Stem Cell-Based Drug Screening by Use of Artificial Intelligence
Induced pluripotent stem cells (iPSCs) are terminally differentiated somatic cells that differentiate into various cell types. iPSCs are expected to be used for disease modeling and for developing novel treatments because differentiated cells from iPSCs can recapitulate the cellular pathology of pat...
Main Authors: | Dai Kusumoto, Shinsuke Yuasa, Keiichi Fukuda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/5/562 |
Similar Items
-
Induced Pluripotent Stem Cells (iPSCs)—Roles in Regenerative Therapies, Disease Modelling and Drug Screening
by: Mourad A. M. Aboul-Soud, et al.
Published: (2021-09-01) -
The Role of E3s in Regulating Pluripotency of Embryonic Stem Cells and Induced Pluripotent Stem Cells
by: Yahong Wu, et al.
Published: (2021-01-01) -
Generation of mouse induced pluripotent stem cells using polycistronic lentiviral vector in feeder - and serum-free culture
by: Mahmaud, Akram Faisal
Published: (2015) -
Characterisation of sympathetic neurons and cardiomyocytes derived from human pluripotent stem cells and their therapeutic mechanism
by: Li, N
Published: (2024) -
Murine pluripotent stem cells that escape differentiation inside teratomas maintain pluripotency
by: Yangli Pei, et al.
Published: (2018-01-01)